| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: | 9 | 1 | 4 | 37 |
 | Floating Genes Early cancer diagnosis in liquid biopsy by ultra-sensitive ctDNA sequencing. Early cancer detection from liquid biopsies | 7 | 6 | 1 | 4 |
 |  Calmedica Mettre la e-santé à la portée de tous Calmedica propose des outils électroniques interactifs de prise en charge et de suivi médical reposant sur les nouvelles technologies de communication. Nos outils sont basés sur une plateforme d'intelligence artificielle unique permettant d'instituer une véritable conversation automatisée par sms. Notre outil Memoquest appliqué au domaine de la santé et à la gestion par un médecin spécialiste d'un patient ambulatoire permet de recueillir les réponses des patients à des questions ciblées et de déclencher des alertes par mail si, et seulement si, le patient fait une réponse pré-définie comme anormale. Particulièrement utilisé en … Type: | 22 | 8 | 18 | 2,053 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | L'Escalator [Automatic translation follows] The incubator driven by Maurice Lévy for all entrepreneurs who lack a network, training or financing The Escalator is not an incubator like any other! Of course, He provides an inspiring place, equipment, and possibly capital. But above all it is driven by Maurice Lévy and his first-rate partners, who are strongly committed to supporting the incubated projects. And that makes all the difference. Type: | 29 | 12 | 21 | 18 |
 | MILVUE NEW TECH, NEW CARE Thanks to their cooperation with providers and manufacturers from the healthcare community, Milvue responds to new challenges in medical imaging by creating a dedicated AI solution integrated into radiologists’ daily routine. This scalable solution helps them make faster diagnoses, better manage patients’ workflows, and focus even more efficiently on patients. They offer more than technical innovation: they are engaged in a medical, social, and societal revolution that puts practitioners back at the center of healthcare strategies. Our AI does not replace radiologists, it makes them irreplaceable. The Milvue Suite software, developed by Milvue, is a Class … Type: | 27 | 9 | 21 | 51 |
 | Groupe IRCEM [Automatic translation follows] Supporting the family: our priority The IRCEM Group is a key player in the social protection of family employment. We support more than 5 million customers (individual employers, home-based employees and retirees from the sector) in the areas of Supplementary Retirement, Protection, Mutual Insurance, Social Action and Prevention. A jointly managed, non-profit association, our vision of social protection is humanist and innovative. It is expressed through our purpose: “Optimizing the disability-free life expectancy of our audiences”. In order to best serve our customers, we regularly look for new talents to support us in our development. Actuarial science … | 7 | 3 | 3 | 333 |
 | Eligo Bioscience Precision medicines for the microbiome Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. | 15 | 8 | 2 | 41 |
 | PhDTalent [Automatic translation follows] Put talent on your side. PhDTalent is the reference in terms of connecting the economic and scientific worlds. It allows companies, institutions and investors access to useful scientific knowledge and resources, produced through an intimate understanding of the world of research and business, to serve development projects. Our digital platform offers companies a multitude of tools to interact with researchers: targeted job offers, specialized CV library, digital recruitment events and scientific expertise missions. Through our digital platform, companies can easily access qualified profiles, increase their visibility among PhDs and delegate specialized missions to our researchers. In addition … Type: | 64 | 13 | 60 | 14 |
 | MedTech in France [Automatic translation follows] We are the French medical technology companies, we innovate every day for patients! Created in 2013, MedTech in France currently brings together more than 40 French companies in the health MedTech sector. and telemedicine, optical technologies, surgical robotics, and even medical imaging. The Association develops concrete solutions to promote market access, innovations and highlight French excellence in medical technologies. It has also set itself the mission of creating French champions internationally. MedTech in France has set itself a triple ambition: > provide medical solutions for patients and caregivers > bring economic and organizational benefits to the health … Type: | 25 | 4 | 22 | 7 |
 | Inserm Transfert Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health. Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of … Type: | 57 | 23 | 40 | 121 |
 | Imagine Institute of Genetic Diseases Institut Imagine, pour guérir les maladies génétiques. Imagine Institute for genetic disease is a French translational research institute which performs state-of-the-art research in order to better understand genetic diseases. The Institute brings together scientists and physicians around the patients in a unique, ultra-modern 19,000 sqm building located within Necker Children’s Hospital, Paris. The teams also benefit from cutting-edge technological platforms and clinical facilities providing methodological advice as well as huge and rationalized cohorts of patients. The objective is to foster translational research and accelerate the development of new therapeutic and diagnostic solutions for the ultimate benefit of the patients and … Type: | 43 | 18 | 33 | 414 |
 | Getinlabs [Automatic translation follows] Getinlabs, so that companies adopt the public research reflex Getinlabs is a source of information for companies, from all sectors, who would like to collaborate with French public research while benefiting from the support of developers. Getinlabs also offers a range of free services for businesses such as a technology exchange or a directory of ecosystem players. The objective of Getinlabs is to develop the visibility of the promotion of public research among companies, to show all the opportunities it can offer and to be a showcase for the successes of public research / company collaborations. Businesses, … Type: | 17 | 3 | 13 | 1 |
 | Fondation Pour l'Audition [Automatic translation follows] 🤝 Foundation recognized as being of public utility since 2015. “Let’s stay tuned to life. » The Fondation Pour l'Audition has been recognized as being of public utility since 2015 and works daily to advance the cause of hearing health. This heritage imbues the brand with a culture of concrete and positive field action. An action which aims to support scientific and medical research, raise awareness, break the taboo and change the way we view the deaf, the hard of hearing and their loved ones. The Hearing Foundation wishes to create synergies by bringing together talents to … Type: | 32 | 4 | 24 | 13 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 10 | 9 | 4 | 37 |
 | Lightinderm [Automatic translation follows] Develops innovative technological systems for skin care intended for home use. Lightinderm is a French start-up hosted at Cochin Hospital in Paris, which develops innovative technological systems for skin care intended for use at home. Inspired by dermatological treatments, its multi-patented innovation combines for the first time photobiomodulation, photo-active serum capsules and tissue massages. This unique combination activates the natural regeneration of cells and visibly improves the quality of the skin. 9 years of research - 43 patents - 7 clinical studies Medical Devices and Cosmetics Type: | 1 | 1 | 0 | 16 |
 | Cardiawave Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis. Innovation prize winner of many contests, Cardiawave is a clinical-stage company which develops an innovative non-invasive image-guided medical device (MD) to treat aortic valve stenosis with ultrasound technology. Aortic stenosis is a life-threatening disease which is a major public health concern in Western countries (10 million people affected). The MD uses focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. The company was created at the end of 2014 as a result of a long-term partnership between the Langevin Institute / Physics for Medicine Paris, … Type: | 20 | 12 | 11 | 36 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing Tags: FrenchTech2030 Type: | 12 | 7 | 8 | 44 |
 | INSERM [Automatic translation follows] Science for health Created in 1964, the National Institute of Health and Medical Research (Inserm) is a public scientific and technological establishment, placed under the dual supervision of the Ministry of Higher Education and Research and the Ministry of Health. Its researchers aim to study all diseases, from the most frequent to the rarest, through their biological, medical and population health research work. Inserm, health researcher since 1964 With a 2013 budget of €927 million, Inserm supports nearly 300 laboratories spread across France. All of its 1,200 teams bring together nearly 15,000 researchers, engineers, technicians, managers, university … Type: | 104 | 90 | 10 | 18 |
 | ICM - Institut du Cancer de Montpellier [Automatic translation follows] Our ambition is to offer each patient personalized and comprehensive care. The ICM, Regional Cancer Institute of Montpellier, is one of the 19 Cancer Centers (CLCC) which constitute the UNICANCER Federation. A Private Health Establishment of Collective Interest (ESPIC), providing a public hospital service and recognized as being of public utility, the ICM is the center of reference and excellence at the regional level in cancer research and care. patients with cancer. All ICM staff, like all CLCCs, share common values to offer optimal care to our patients: humanism, excellence, solidarity, innovation. #EmployerBrand #QualityOfLifeAtWork #QVT #Innovation #Recruitment … Type: | 36 | 14 | 19 | 452 |
 | Fédération Française des Industries de Santé - FEFIS [Automatic translation follows] The ambition to put its action at the service of public health policy, a source of social and economic progress. Created in 1975, the French Federation of Health Industries – Féfis – brings together eleven professional organizations representing companies which create, manufacture or distribute health products such as human and veterinary medicines, medical devices, optical products, dental products, in vitro diagnostics. A crossroads for exchanges and common actions, Féfis strives to be the spokesperson for a strategic sector of the future for the growth and competitiveness of our country. His commitments within numerous structures – ARIIS, MEDEF, … Type: | 26 | 6 | 21 | 6 |
 | Blue Factory ESCP [Automatic translation follows] Opening ways for entrepreneurs The Blue Factory supports students and alumni entrepreneurs from ESCP Business School and Partners, at every stage of their entrepreneurial journey. We currently have 3 programs: > START: from idea to prototype > SEED: from prototype to market-fit > SCALE: from market-fit to scale Our focus is to help entrepreneurs growing projects that matter for them and for the world, whatever the sector => check some here https://www.blue-factory.eu/fame#blue-stories We are also a founding member of La Boussole des Entrepreneurs, and a member of the ESCP Say Insitute. ------ The Blue Factory supports ESCP … Type: | 21 | 7 | 15 | 10 |
 | French Healthcare Official English account of #FrenchHealthcare, an innovative public-private initiative promoting the healthcare 🇫🇷🩺 French Healthcare is a public-private initiative aimed at bringing together French companies, researchers, and healthcare professionals to jointly promote their activities internationally. This initiative is supported by the Ministry for Europe and Foreign Affairs, Business France and the French Healthcare Association. The collective brand French Healthcare has the ambition to build momentum through a collective approach so as to boost the influence of French expertise, know-how and technologies in the Healthcare industry. Type: | 38 | 10 | 32 | 4 |
 | Les Startups à l'Ecole [Automatic translation follows] Bringing together school audiences and innovative startups within the framework of educational projects. Initiated by the deeptech incubator Agoranov in 2015, the Startups at School approach allows school audiences (from 6th grade to BAC +2) to meet entrepreneurs and work on educational and innovative projects. Thanks to the Startups at School program: - Middle school students imagined and designed a snack based on microalgae with the startup Algama. - High school students have developed a connected watch with the startup LifePlus for people in the process of becoming vulnerable. - A BTS Commerce International class discovered what … Type: | 6 | 1 | 6 | N/A |
 | SKAIROS [Automatic translation follows] Simulate all, keep the best ▶ Digital spine twins for personalized medicine SKAIROS' activity is based on the ambition of bringing the first digital twins of the spine to clinicians and implant designer manufacturers, by providing a global support service from the design phase of innovative implants and pre-market validation through to their clinical use and post-market evaluation. Type: | 2 | 2 | 0 | 5 |
 | OMENA Daily support to deal with menopause from home OMENA is a simple app with 3 key features : 1. Articles to understand menopausal symptoms, 2. Personalized lifestyle programs to reduce your symptoms, 3. Community to share your feelings and experiences OMENA creates personalized well-being programs & contents based on initial questionnaire answers about your menopause. These programs are easy to follow thanks to daily reminders and progression tracking. A strong community for support & peer-to-peer advice from other women will keep you motivated. Well-being, Personalization, Community, Menopause, Companion, Ménopause, Personnalisation, Communauté, Accompagnement, and Bien-être Type: | 6 | 4 | 3 | 14 |
 | PEP-Therapy Innovative peptides as targeted therapies for oncology PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors. cell penetrating peptide, protein-protein interaction, targeted therapies, oncology, clinical trial, and cancer Type: | 4 | 3 | 1 | 14 |
 | Ganymed Robotics Orthopedics for visionaries There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. It's going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldn't be a direct result of the surgeon's state of mind. We believe it's possible to create tools that will improve both patient … Tags: FrenchTech2030 Type: | 20 | 11 | 9 | 52 |
 | MyReVe [Automatic translation follows] Our ambition is to give everyone the opportunity to overcome their fears through virtual reality. MyReVe is a virtual reality broadcast platform aimed directly at people suffering from fears Virtual reality, Data Science, anxiety disorders, phobia, fear of flying, claustrophobia, agoraphobia, PTSD, PTSD, and algorithm Type: | 2 | 2 | 0 | 3 |
 | Auriga Partners [Automatic translation follows] Supporting those who challenge the status quo Since its creation in 1998, Auriga Partners has been a pioneer in venture capital investment in France and Europe with more than 120 companies financed in IT and Life Sciences. Because the innovation environment is ever more complex to understand, Auriga Partners is now implementing a multi-specialist investor strategy whose purpose is to rely on talents, business expertise and ecosystems. to create and develop specialized thematic funds. With the ambition to generate maximum value for entrepreneurs and ultimately for investors. The funds are deployed in capital on start-ups / scale-ups … Type: | 5 | 5 | 0 | 11 |
 | Entreprendre [Automatic translation follows] Entreprendre, the magazine for entrepreneurs since 1984 Entreprendre, the favorite magazine for entrepreneurs. Every month on newsstands, companies that are making progress, SMEs to follow and young startups, but also major interviews with renowned entrepreneurs. Type: | 20 | 7 | 4 | 21 |
 | ICONEUS Delivering functional ultrasound (fUS) imaging solutions to help scientists understand the Brain function Real-time portable functional ultrasound neuro-imaging ICONEUS is introducing functional ultrasound neuro imaging: a breakthrough imaging modality for brain activity monitoring based on blood flow imaging with ultra-high sensitivity. For preclinical research, the portability and high versatility of our technology enables the study of brain activity at unprecedented scales and in a large variety of subject states: awake, behaving, freely-moving, resting-state and asleep conditions. Our technology can be easily combined with other complementary modalities such as eeg headstage or optogenetics which are inherently difficult to combine with fmri. … Type: | 8 | 4 | 6 | 33 |
 | Novanexia Boost your innovation Supporting public organisations and private compagnies in setting up European innovation projects such as EIC Accelerator, Transition & Pathfinders, Horizon Europe collaborative projects (IA, RIA and Eurostars), national projects such as i-Demo, i-Lab and i-Nov (France 2030). Our goal is your success and we are committed to sharing with you all the expertise in order to assist you in the optimisation of your research and innovation projects. Together we can turn your ideas into winning projects! You can also find us on Twitter: https://twitter.com/novanexia Have a closer look and contact us with any questions or inquiries. Type: | 7 | 2 | 5 | 8 |
 | Institut Pasteur de Lille Accélérer la recherche et agir pour la santé de demain The Institut Pasteur de Lille foundation was created in 1894 by the will of Louis Pasteur, Albert Calmette and the local officials. Member of the Pasteur Institute international network, the fondation is acting to make people live longer and healthier by 2 means : Fondamental Research and Prevention. In addition to infectious diseases, its historical research topic, cancer, cardiovascular and neurodegenerative diseases are now part of the main research areas of the foundation Recherche scientifique, Santé publique, Recherche médicale, and fondation Type: | 24 | 15 | 12 | 353 |
 | Institut Pasteur The Institut Pasteur is a leading global biomedical research institute. The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research with a network of 33 members worldwide. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its … Type: | 34 | 26 | 16 | 4,162 |
 | Le Monde [Automatic translation follows] The leading news, everywhere, all the time, from the editorial staff of Le Monde. LeMonde.fr has been present on the Internet since December 19, 1995, 51 years to the day after the creation of the paper newspaper. The site and its mobile applications are among the most consulted in France to follow news in real time (international, economy, politics, society, etc.) Leading news website in French. Journalism, Media, Online Press, Written Press, Internet, Video, and Ethics Type: | 274 | 196 | 76 | 2,722 |
 | AbilyCare The digital solution to measure one's walk and balance Based on French research, Abilycare was developed by and for practitioners. AbilyCare is a solution that measures walk and balance in order to prevent frailty risks at any moment of our life. It's a medical device (certification in progress), easy and fast to use in order to : - detect early signs of frailty - develop preventive actions to initiate the process of reversibility - monitor the patient's state over time and measure the benefit of a rehabilitation or prevention program Type: | 12 | 4 | 7 | 7 |
 | BIOCODEX Healthcare with passion and conviction Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,600 employees, Biocodex generated net revenues of above €500 million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide. To report quality complaint(s) or adverse event(s) related to Biocodex products please visit … Type: | 6 | 5 | 0 | 1,418 |
 | ENDODIAG Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients worldwide!). Located in Evry, France, within Genopole, the French largest Biocluster, the company leverages the experience of its scientific cofounders who have been working in this field for over 20 years and a network of major hospital centres both in France and abroad. Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes … Type: | 6 | 4 | 0 | 9 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 31 | 12 | 22 | 210 |
 | Université Paris Cité Compte officiel. Université Paris Cité, Illuminons le monde de demain. #EnlightenTheFuture This university of intensive research embodies the incarnation of a Modern Paris. It contributes to a higher education, research and innovation in France, but also to the European and International dimension of research and formation. Université de Paris based on the strength of its pioneer’s campuses, Paris Descartes, Paris Diderot, and the IPGP, helps develop and convey knowledge serving women, men and society. Sciences are significant in Université de Paris, such as health sciences, human and social sciences; it displays an omni-disciplinary institution. Labelled IdEx since March 2018, Université … Type: | 43 | 14 | 19 | 6 |
 | Cleantech Business Angels Cleantech Business Angels Investments in Cleantech Startups STARTUP, BUSINESS ANGELS, FINANCEMENT, Cleantech, Greentech, Energie, EnR, Hydrogene, Biomasse, Transition energetique, Photovoltaique, Eolien, Energie marine, Recyclage, Biodiversité, Environnement, Ecologie, Transition écologique, SDG, ODD, Investisseurs, Fonds, ImpactTech, and ClimateTech Type: | 6 | 2 | 2 | 7 |
 | DEXTRAIN [Automatic translation follows] “Dextrain is about Dexterity Technology & machine learning improving neuro recovery and prediction” Dextrain develops medical technologies based on neuroscience for the diagnosis and treatment of hand deficits. We focus on transferring science to clinical practice by developing clinically useful, affordable and accurate technology and digital tools. We provide rehabilitation solutions for orthopedics and neuro-rehabilitation that promote the recovery of manual dexterity, prediction and prevention, to contribute to autonomy in daily activities and improve quality of life. MedTech and Neuro Rehabilitation | 6 | 5 | 0 | 5 |
 | Angels Santé The leading European Business Angels network in healthcare investment Europe’s number one Business Angel Network for Health Angles Santé investors provide their funds and expertise to start-ups with strong potential to support their launch and development. Our mission at Angels Santé: to detect European start-ups that meet the challenges of our health systems with economically responsible solutions and strong medical benefits, to boost seed-stage development by providing direct capital, expertise and networks, to mobilize non-specialized investors towards health investment to meet the needs of ambitious projects. Our members invest in healthcare projects that they understand, thanks to their expertise and … Type: | 60 | 11 | 45 | 74 |
 | G_NIUS [Automatic translation follows] Stimulating digital health innovations G_NIUS: the national window that makes life easier and saves time for digital health innovators. G_NIUS is the National Window for Innovation and Uses in e-Health. It helps you decipher the regulatory framework, identify the main players in the ecosystem and understand the methods of financing and access to the market . You are thus directed to the right resources and the right contacts to best anticipate the stages of your projects and their developments. Planned by the ministerial roadmap for digital health and accelerated within the framework of France 2030, G_NIUS is … Type: | 26 | 6 | 21 | 1 |
 | Novéka ! [Automatic translation follows] Taking care of innovation Entirely dedicated to connecting and collaborating individuals, Novéka contributes to promoting the skills and know-how of the local ecosystem in the service of innovation, transformation and development of companies in the health sector and, in particularly medical devices and e-health in the AURA region. Type: | 28 | 13 | 23 | 5 |
 | Faculté de Pharmacie Montpellier [Automatic translation follows] Created more than 200 years ago, the Faculty of Pharmacy of Montpellier is among the largest in France with more than 2,300 students and nearly 400 teaching-researcher staff, teachers, researchers and administrative and technical staff. Anchored in its territory, the faculty gives an essential dimension to Montpellier pharmaceutical sciences by offering courses responding to scientific and societal challenges, and by contributing to the development of research in areas of excellence such as chemistry, the environment, agro-sciences... Type: | 8 | 4 | 5 | 107 |
 | Centre de Dépistage des Cancers IDF [Automatic translation follows] Coordinate cancer screening in Ile-de-France to reduce cancer mortality and save lives. The Île-de-France Regional Cancer Screening Coordination Center (CRCDC-Île-de-France), was born on May 1, 2019 following the Decree of March 23, 2018 on the regionalization of cancer screening management structures implemented throughout France. The CRCDC-IDF therefore resulted from the merger of the 8 departmental structures for managing organized screening in Île-de-France. These territorial sites have been maintained, allowing a strong territorial anchoring of our activities. The CRCDC-IDF's mission is to promote, organize and evaluate organized cancer screenings in Île-de-France with the aim of reducing cancer mortality … Type: | 6 | 3 | 2 | 40 |
 | aKen Medical The Next-generation of personalized and adaptive radiotherapy. αKen Medical is a biotechnology company aiming to develop and bring to market the Next-generation of personalized and adaptive radiotherapy for treating solid cancer tumors. The proposed therapies seek to improve the effectiveness of alpha therapy and reduce its side effects. Radiotherapy, Cancer treatment, Brachytherapy, Targeted therapy, Biotechnology, Medical devices, Alphatherapy, Nanotechnology | 7 | 3 | 2 | 3 |
 | En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing Type: | 3 | 2 | 2 | 6 |
 | METAFORA biosystems AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, and research Type: | 15 | 2 | 12 | 35 |
 | EG 427 Pinpoint Gene Therapy - We are Hiring! At EG427 our unique, non-replicative Herpes Simplex Virus type 1 (HSV-1) based vector platform delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes for use in the treatment of peripheral nervous system disorders and beyond. Our lead asset EG110A, for the treatment of neurogenic bladder dysfunction, is expected to be in the clinic by early 2024. Our revolutionary approach to the treatment of this disease aims at providing patients with a comprehensive, long-term solution to their bladder management, through a highly selective molecular biology approach overcoming the drawbacks of current … Type: | 2 | 2 | 0 | 20 |
 | Scipio bioscience Single-cell sequencing on every benchtop At Scipio bioscience we are passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio propels the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provides all researchers with Empowered Autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for the highest-quality results and true biological information. We will be glad … Type: | 2 | 1 | 1 | 26 |
 | Egle Therapeutics Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones. Type: | 1 | 1 | 0 | 33 |
 | Union Mutame [Automatic translation follows] Present in the protection of territories for more than 60 years, Mutame is a union of committed and independent mutual societies with their own contracts and guarantees, approved or certified. All members of the French Mutualité, there are currently three of them: Mutame & Plus, Mutame Savoie Mont-Blanc and the Mutuelle Marseille Métropole/Mutame Provence. They therefore cover the entire territory thanks to their complementary local service and bring together around 100,000 protected people. Why a Union? Our mutuals are united around values of protection, solidarity and prevention, which they communicate by pooling their actions through Union Mutame. … Type: | 30 | 0 | 30 | 12 |
 | CGenetix From hope to reality Young start-up that aims to revolutionize precision medicine by developing innovative and non-invasive diagnostic tests dedicated to monitoring patients with various pathologies. CGenetix is mainly focus on the development of its first diagnostic test dedicated to kidney graft monitoring in transplant patients. biologie moléculaire and Bio-informatique Type: | 4 | 4 | 2 | 3 |
 | INCA Type: | 3 | 3 | 0 | 1,312 |
 | Institut Cochin Biomedical Research Center The Institut Cochin is a research center under the joint administrative supervision of Inserm (U1016), CNRS (UMR 8104) and Paris Cité University (UMR-S1016). The Institute hosts around 650 researchers, clinicians, teacher-researchers, technical and administrative engineers, postdoctoral fellows, doctoral students, and trainees. It has 41 teams and ten technological platforms. Together, we share the objective to advance knowledge of the biological mechanisms controlling physiological and pathological situations in humans. The main lines of research of the Institute are cancer, immunology, endocrinology-metabolism, microbiology, and genetic and cellular plasticity. Research is carried out on the campus of the Cochin-Port-Royal Hospital, … Type: | 12 | 1 | 5 | 239 |
 |  Buzz E-santé [Automatic translation follows] Digital is not a revolution but an awareness! Information media on digital health. E-health, telemedicine, web health, m-health, connected health... will no longer hold any secrets for you! digital, e-health, telemedicine, digtal pharma, and connected health Type: | 50 | 2 | 50 | 1 |
 | Keyrus Life Science The C2RO that helps connect Industry Expertise, Life Data Sciences and Digital Enablement. Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech … Type: | 2 | 2 | 1 | 211 |
 | SINGA Accelerating newcomers' inclusion✊🌍 Accélérer l'inclusion des personnes nouvelles arrivantes✊🌍 EN/FR Founded in 2012, SINGA is an international organization that accelerates the inclusion of newcomers to foster more cohesive, creative, and prosperous societies. The organization now has over 80,000 members in 7 countries and 17 cities. Since its inception, SINGA has supported over 2000 entrepreneurs, facilitated tens of thousands of intercultural encounters, and enabled thousands of solidarity-based cohabitations. /// Créée en 2012, SINGA est une organisation internationale qui accélère l’inclusion des personnes nouvelles arrivantes pour favoriser des sociétés plus soudées, créatives et prospères. L'organisation compte aujourd'hui plus de 80 000 membres … Type: | 61 | 25 | 40 | 12 |
 | SNITEM [Automatic translation follows] To advance health Snitem is the leading professional organization representing the majority of the medical device and Health Information and Communication Technologies industry. It brings together more than 600 companies, representing 90% of a market estimated at 30 billion euros for 90,000 people. SMEs, ETIs and International Groups market a wide diversity of products and technologies (consumables, equipment and technical aids, implants, instrumentation and software, etc.) The main missions of Snitem are to inform, support and unite. At the national level, he is the privileged interlocutor and referent in the field with ministerial offices, the administration and … Type: | 70 | 30 | 44 | 52 |
 | Therapixel Artificial Intelligence for efficient breast cancer screening Therapixel is a leading french software company specialized in artificial intelligence for medical imaging. Our aim is to develop a digital radiologist achieving the performance of best experts. Our AI is dedicated to breast cancer screening. That algorithm won the Digital Mammography DREAM Challenge, the largest Artificial Intelligence challenge ever organized. In its early years, Therapixel developed images visualization software for surgeons to make image access easier and faster from patient consultation to the operating room thanks to gesture control and intuitive user interfaces. Type: | 16 | 12 | 4 | 49 |
 | Ad Scientiam Better data for better care At the heart of Ad Scientiam's project is a conviction: measuring and monitoring the evolution of serious and disabling diseases on a continuous basis and in real life is essential for better management. We make visible these evolutions, until now undetectable, through the design and clinical validation of digital biomarkers. This scientific and technological challenge should enable each patient to be an active participant in their own illness and allow healthcare professionals to offer more individualized and therefore more efficient care. Ad Scientiam thus participates in the development of future treatments and in reducing the … Type: | 18 | 8 | 11 | 67 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … Type: | 21 | 12 | 11 | 38 |
 | EVerZom Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this … Type: | 12 | 12 | 0 | 18 |
 | Foundation For Rare Diseases Foundation for Scientific Cooperation The French Foundation for rare diseases (Fondation maladies rares) is a unique cooperative framework dedicated to rare diseases research. Co-founded by French University Hospitals, Universities, Research organisations and Patients’ organizations, it acts as a strategic hub to coordinate, federate and fund rare diseases research, essentially at the French national level. The French Foundation for rare diseases is a non-profit private structure, created in February 2012. Its support spans from basic, translational and clinical sciences to social and human research towards effective health care for patients affected by rare diseases. The Foundation has built strong links with … Type: | 20 | 5 | 13 | 20 |
 | SCALE-UP BOOSTER [Automatic translation follows] Accelerator of startups with international impact. SCALE-UP BOOSTER is the accelerator specializing in the support and development of startups with an international vocation. Type: | 11 | 1 | 1 | 3 |
 | Coave Therapeutics Coave therapeutics new brand for Horama Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet … Type: | 4 | 2 | 1 | 39 |
 | Quest for change [Automatic translation follows] Grand Est incubator network Since 2018, 6 incubators of excellence in the Grand Est region, spread across 6 territories (Charleville-Mézières, Epinal, Metz, Mulhouse, Reims and Strasbourg), have deployed a common support methodology. This method, sequenced and tested by more than 260 start-ups to date, aims to lead/bring project leaders to meet their market and achieve their financial independence. Our team, made up of 45 experts with strong entrepreneurial DNA, aims to develop innovation in our territory via pragmatic, caring and impartial support. Type: | 77 | 23 | 72 | 27 |
 | Polytech'Grenoble "Polytech GRENOBLEis the engineering school of the UNIVERSITY JOSEPH FOURIER. | 12 | 5 | 6 | 5 |
 | POLEPHARMA [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Polepharma structures the French (bio)pharmaceutical industrial sector and has been supporting its transformation for 20 years. Polepharma has become the first pharmaceutical industrial cooperation in Europe, between areas of excellence and players in the sector: 400+ members, 60% of production & 70k jobs in France. Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma supports its members throughout France. These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, that is to say cutting-edge, virtuous, … Type: | 48 | 27 | 27 | 28 |
 | Pôle BFCare [Automatic translation follows] Bringing together healthcare companies in Burgundy-Franche-Comté to stimulate innovation and attract young talents The BFCare cluster is an association made up of around fifty companies in the health products and services sector, based in Burgundy - Franche Comté, and partners interested in health activities (institutions, private rights organizations, etc.). .). The main objective of this association is: - to facilitate the emergence of cooperation and synergies between members and external actors, - encourage exchanges of good professional practices to develop the competitiveness of businesses - and support regional attractiveness in terms of investment and talent. health, medical … Type: | 17 | 4 | 13 | 3 |
 | Neoloji Technopole [Automatic translation follows] Technopole, Incubator, Business incubator Labeled by the national Rétis Innovation network, Neoloji Technopole aims to develop the territory through innovation and bring together all of its companies and public actors. Our experts individually support innovative companies and project leaders in the incubation, creation and development phase. Our 2 incubators located in the Futuroscope area (CEI site) and in the center of Poitiers (H.TAG site) host these innovation players and are intended to be open places to liven up this constantly evolving ecosystem. The services offered by the Technopole are focused on the needs of entrepreneurs and managers. … Type: | 37 | 14 | 34 | 12 |
 | PCN Cluster 2 Culture, créativité, société inclusive #HorizonEU [Automatic translation follows] Supporting research actors in the human and social sciences and cultural actors towards Horizon Europe The National Contact Point for Cluster 2 of the Horizon Europe financing program is your relay in France to obtain all the information about this program supported by the European Commission. Our team is at your disposal to make you aware of European funding programs, and to support you during the different stages of your application. The National Contact Points are coordinated by the Ministry of Higher Education, Research and Innovation financing and horizoneurope Type: | 96 | 18 | 82 | 1 |
 | Fluigent Smart Microfluidics Fluigent develops, manufactures and commercializes innovative fluid handling solutions for a variety of rapidly growing applications where fluid control is critical. We have delivered microfluidic solutions to hundreds of customers worldwide since 2006. We offer to our customers a full range of engineering services and technical assistance to design and optimize their set-ups. Our solutions are modularized, enabling our customers to save precious time with cumbersome engineering fluidic developments (such as re-designing and re-developing electronic and software interfaces for each new set-up). Quality is at the center of all our activities. Our Customers can benefit from our ISO-9001 … | 11 | 1 | 9 | 65 |
 | Capital Grand Est [Automatic translation follows] Success accelerator Capital Grand Est is a private equity management company. We rely on our investment funds to support companies at different stages of maturity in the Grand Est Region. Capital Grand Est and its team participate in the development and success of start-ups and dynamic SMEs in all sectors. Investment capital is above all a meeting, a human adventure with the leaders of today and tomorrow. Type: | 16 | 9 | 9 | 26 |
 | Ermium Therapeutics Controlling auto-immune diseases Ermium Therapeutics is a discovery stage Biotechnology company developping innovative therapies for auto-immune diseases Type: | 2 | 2 | 0 | 9 |
 | Sonio Securing pregnancy care Sonio is the next generation Women’s Health Practice Management & Reporting Software. Perform every prenatal examination to your highest quality standards with Sonio platform, powered by AI1. Empower your ultrasound practitioners and readers, clinical executives, and IT with a robust, intuitive and easy-to-use platform. Improve efficiency, quality assurance and clinical excellence at each step of the patient’s pregnancy journey. 1AI capabilities are brought through our FDA 510(k) cleared Sonio Detect product and thanks to our MDR-CE marked Sonio Expert product. prenatal diagnosis, prenatal screening, SaaS, prenatal ultrasound sharing, AI, maternal fetal medicine, and prenatal ultrasound Type: | 15 | 10 | 7 | 67 |
 | Brenus Pharma Tumor-antigen focused immunotherapies anticipating tumor plasticity, resistance to treatments and relapses ✔️🟣 Brenus Pharma, french private start-up in biotechnology based in Lyon, develops a platform technology to deliver first-in-class tumor-antigen focused immunotherapy. The STC (Stimulated Tumor Cells) Technology allogeneic platform deliver STC drug product, in 3 major steps: 🟣 Cell Selection to mimic tumor heterogeneity & resistance capacities of the selected indication. 🟣 In vitro induction and overexpression of resistances marker by stimulation with Standard of care and Rx. • 100+ cancer related surface proteins over expressed • Cross-matching human tumoral biopsy databases • Covering 3 categories of targets (Tumor … Type: | 16 | 5 | 9 | 14 |
 | Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: | 9 | 4 | 7 | 7 |
 | PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: | 1 | 1 | 0 | 15 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech Type: | 9 | 2 | 7 | 11 |
 | Silver innov' [Automatic translation follows] The Address of Health Innovation · Aging · Disability Ready to propel your innovative projects towards success? 🚀 Silver innov' is THE solution! The only business incubator and hotel dedicated to the silver economy in France, we offer accommodation and support solutions on the outskirts of Paris in the Grand-Orly Seine Bièvre region. 🏢 Turnkey Hosting: Located in the heart of Grand-Orly Seine Bièvre, a territory of innovation and industry, Silver innov' offers you plug & play. Whether you are more or less than 4 years old, our “Corporate Hotel” or “Nursery” solutions adapt to your needs … Type: | 23 | 5 | 17 | 8 |
 | Consorzio Arca [Automatic translation follows] Business incubator of the University of Palermo The ARCA Consortium is the Business Incubator of the University of Palermo whose mission is to promote and assist the birth of innovative entrepreneurial initiatives. Over the years we have supported the launch of academic startups and spin-offs with a high rate of innovation. The Arca Consortium, a consortium for the application of research and the creation of innovative companies, active since 2003, is a partnership between the University of Palermo and a private entrepreneurial group engaged in the field of industrial research and technology transfer. The incubator is located … Type: | 24 | 0 | 21 | 5 |
 | Biotech Santé Bretagne [Automatic translation follows] Accelerate your innovations, our experts support you Biotech Santé Bretagne (BSB) is a certified technological innovation center. Its objective is to support innovation in Brittany while structuring and driving the biotechnology and health sectors. BSB operates in 7 markets: eco-industry, agro-industry, food, cosmetics, biotech/pharma, medical technology and e-health. Biotech Santé Bretagne supports companies and all project leaders through comprehensive expertise: advice, monitoring, connection with partners, project engineering, product feasibility study, development strategy, identification of financing, support for Europe and internationally. Through innovation and the promotion of sectors, Biotech Santé Bretagne enables the development of research and innovation, … Type: | 61 | 22 | 43 | 18 |
 | BIOMUNEX PHARMACEUTICALS BIOMUNEX is a biopharmaceutical company focused on the discovery and development of breakthrough immunotherapeutics BIOMUNEX Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of breakthrough immunotherapies using its Unique BiXAb® technology to create next generation bi- and multi-specific antibodies. Our disruptive biological approaches target a number of cancer types, in particular where there are unmet medical needs. We are committed to provide oncologists and patients with immunotherapies that are novel, efficacious and prolong life expectancy. | 4 | 3 | 1 | 12 |
 | Robeauté Therapeutic microrobots, smaller than a grain of rice At Robeauté we are developing a really small microrobot for novel therapies in hard-to-reach areas of the body. Designed specifically for the brain, at the service of neurosurgeons, our microrobot will be able to freely navigate in other complex regions of the body to perform biopsies, collect precise anatomically localized data and deliver therapies on site, at the right dosage. We are accompanying a major shift from robotic surgery to microrobotic surgery, for greater precision, better results and bold new therapies to tackle global diseases affecting more than a billion people worldwide. … Type: | 10 | 5 | 7 | 25 |
 | Jellynov Jellynov is a medtech start-up fighting overweight. Jellynov is a medtech start-up fighting overweight. | 2 | 2 | 1 | 7 |
 | Parean Biotechnologies Deep Immune Phenotyping & MultiOmics DataScience, for immune precision medicine Parean Biotechnologies is a pioneering service company dedicated to advancing preclinical and clinical programs in the field of oncology and immune related diseases. Our comprehensive approach integrates an in-house wet lab (cytometry, cell sorting, libraries generation in bulk or single cell protocols) and a cutting-edge data science unit to drive innovation and foster transformative breakthroughs. Key offerings includes: - Deep Immune Phenotyping Expertise: Acting as an interim research team, we provide unparalleled proficiency in deep immune phenotyping, with a focus on T-Cell, B-Cell, NK, and other immune cell subsets. - … Type: | 2 | 2 | 0 | 8 |
 | BADGE Business Angels des Grandes Ecoles [Automatic translation follows] BADGE, one of the leading Business Angel networks in France. More than 15 years serving innovation. Since 2004, the Business Angels of the Grandes Ecoles have financed more than 229 companies by providing more than €51 million which, through effect on other sources of financing, have generated more than €130 million in capital contributions in these companies. Its members, with recognized professional experience, participated in 29 fundraising events in 2023, bringing €4.5 million to rapidly developing companies. Our objective is to support the creation, development and financing of start-ups with high growth potential in technological and service … Type: | 21 | 6 | 16 | 37 |
 | Wacano [Automatic translation follows] Entrepreneurs who build the future Entrepreneurship hubS within Paris and region 350 startups are accompanied each year to grow - 800 entrepreneurs - 13 hubs Support for business creators, Hosting, Networking, Innovation, Passion, and Entrepreneurship Type: | 31 | 8 | 0 | 34 |
 | NeuralTeks Grow Your Laboratory with Artificial Intelligence NeuralTeks est une start-up innovante qui développe une plateforme d'analyse d'images basée sur l'intelligence artificielle, destinée à révolutionner les méthodes d'identification et de comptage des micro-organismes en laboratoire. Notre technologie permet une analyse rapide, précise et fiable directement depuis un smartphone, une tablette ou un microscope, améliorant ainsi l'efficacité des laboratoires de microbiologie. NeuralTeks is an innovative start-up developing an artificial intelligence-based image analysis platform designed to revolutionise the way micro-organisms are identified and counted in the laboratory. Our technology enables fast, accurate and reliable analysis directly from a smartphone, tablet or microscope, improving … Type: | 13 | 2 | 11 | 3 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Drug Discover, Computational Chemistry, Molecular Dynamics Simulation, and Quantum Physics Tags: FrenchTech2030 Type: | 45 | 17 | 35 | 59 |
 | Raidium Raidium foundation model : Radiology augmented GPT to tackle the complexity of precision medicine Build the first Radiological Foundation Model Bring the radiological image to GPT Share the world's top medical expertise through AI Bring the best specialist to every patient/researcher/company artificial intelligence, radiology, medical imaging, and foundation model Type: | 5 | 2 | 4 | 9 |
 | EPPUR [Automatic translation follows] Do you want to brake free?! 🦽 Dreeft, the 1st pair of wheels for manual wheelchairs which includes a braking system 👨🏻🦽 Braking in a wheelchair today means using your hands like brake pads: burns, significant strain on your arms and accessibility problems. With Dreeft, the first braking system for wheelchairs, it's over! Dreeft is a pair of wheels adaptable to any manual wheelchair. A simple backward action of the handrail results in progressive braking in the center of the wheel. 🔥 100% of hand burns eliminated 💪 5x less effort for identical braking 🐓 Entirely made … Type: | 30 | 7 | 29 | 11 |
 | Careside [Automatic translation follows] The entire patient journey on a single platform: pre-admission, hospitalization, discharge and post-hospitalization follow-up. ➡️ Manage your patients' journey on a single platform: administrative and medical preparation, hospitalization, discharge and post-hospitalization follow-up. ✅ Careside is La Poste Santé & Autonomy. Its offering makes it possible to improve care and provide each patient with an optimal digital and human experience. ✅ Careside is part of a global strategy of the La Poste Group in health, which is to become the reference partner for health professionals, health establishments and industries around human proximity services for home health and trusted … Type: | 11 | 3 | 8 | 253 |
 | Quattrocento [Automatic translation follows] Quattrocento is not an inventor, he is an innovator! Revitalizing the French industrial fabric is a major economic challenge. This is why Quattrocento manufactures solid SMEs, exporters of equipment for medical and biological research, by combining proximity with academic researchers, a network of French industrial partners and a network of involved investors. Type: | 4 | 1 | 3 | 13 |
 | GenoSplice technology GenoSplice provides high-level Bioinformatics services for Genomics projects. Our organisation is leader in next generation sequencing and microarray data analysis, with specific expertise in alternative splicing. Our main goals are: • allowing to manage a huge quantity of data from your laptop with our dedicated platform, • turning raw complex data into easy-to-interpret biological information. Bioinformatics, Alternative Splicing, Sequencing, and RNA-Seq Type: | 2 | 2 | 0 | 8 |
 | PhinC Development 15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities … Type: | 6 | 2 | 5 | 16 |
Startup